LifeMD (LFMD) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Clean Climate Climate Change Contaminant Ecosystem Emission Environment Environmental Materials Nature Ocean Offset Package Packaging Pandemic Raw Materials Renewable Waste Water Access Affordability Asian Benefits Black California Consumer Privacy Act Charitable Collective Bargaining Community Culture Customer Customer Satisfaction Cyber Cyber Security Cybersecurity Data Privacy Data Security Death Demographic Disability Diversity Employee Engagement Gender Health and Safety Health Care Healthcare Hire Hiring Human Capital Human Rights Human Trafficking Incident Injury LGBTQ OSHA Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Stakeholder Supplier Supply Chain Supply Chain Management Talent Training Union Women Workforce Action Plan Anti-corruption Assessment Assurance Attorney General Attorneys General Audit Bonus Bribe Bribery Chronic Class Action Lawsuit Commitment Conflict of Interest Controversy Corporate Governance Corporate Purpose Corruption Department of Director Resignation Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigant Litigation Long-term Majority Mission Oversee Oversight Plaintiff Proxy Contest Purpose R&D Recoup Reputation Reputational Responsibility Responsible Self-evaluation Special Meeting Strategy Targets Tax Tenure Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 24, 2021, the Company held an annual meeting of stockholders (the “Annual Meeting”). A majority in interest of all stock issued, outstanding and entitled to vote at the Annual Meeting were present in person or by proxy, thereby constituting a quorum.

The matters voted upon and approved by the Company’s stockholders were:

	(1)	The election of eight directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified (“Proposal 1”).
	(2)	The approval of an amendment to the “2020 Plan to increase the number of shares of the Company’s common stock available for issuance under the 2020 Plan by 1,500,000 shares (“Proposal 2”).
	(3)	The approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers as disclosed in the Proxy Statement (“Proposal 3”).
	(4)	The recommendation, on a non-binding advisory basis, on the frequency of future advisory votes on the compensation of the Company’s named executive officers (“Proposal 4”).
	(5)	The ratification of the selection of Friedman LLP as LifeMD’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (“Proposal 5”).

The following is a summary of the voting results for each matter presented to the shareholders:

Proposal 1:

Director’s Name	Votes For	Votes Withheld	Broker Non-Votes
Justin Schreiber	12,433,875	39,147	5,736,727
Stefan Galluppi	12,435,496	37,526	5,736,727
John R. Strawn, Jr.	10,780,081	1,692,941	5,736,727
Happy Walters	12,425,590	47,432	5,736,727
Bertrand Velge	11,009,506	1,463,516	5,736,727
Dr. Joseph V. DiTrolio	11,905,775	567,247	5,736,727
Dr. Eleanor C. Mariano	12,433,241	39,781	5,736,727
Roberto Simon	12,433,902	39,120	5,736,727

Proposal 2:

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
10,378,379		1,886,624		208,019		5,736,727

Proposal 3:

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
12,272,487		121,337		79,198		5,736,727

Proposal 4:

One Year Votes For		Two Years Votes For		Three Years Votes For		Votes Abstained		Broker Non-Votes
2,082,424		80,554		10,257,592		52,452		5,736,727

Proposal 5:

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
18,119,574		16,276		73,899		N/A

All Proposals were approved. We have determined to hold an advisory vote every three years on executive compensation, based on our stockholders’ support for this alternative in Proposal 4.